Subscribe to RSS
DOI: 10.1055/s-0031-1290130
Alkyne-Assisted Approach to the Formal Synthesis of Antibiotic Macrolide (-)-A26771B
Publication History
Publication Date:
03 January 2012 (online)
![](https://www.thieme-connect.de/media/synlett/201202/lookinside/thumbnails/10.1055-s-0031-1290130-1.jpg)
Abstract
A stereoselective formal synthesis of a 16-membered antibiotic macrolide (-)-A26771B is described starting from (R)-propylene oxide and (+)-diethyl tartrate. Key steps involved in this alkyne-assisted convergent approach are alkyne zipper reaction, Cadiot-Chodkiewicz coupling, and Yamaguchi macrolactonization.
Key words
alkyne - macrolide - zipper reaction - Cadiot-Chodkiewicz reaction - Yamaguchi macrolactonization
- 1
Michel KH.Demoarco PV.Nagarajan R. J. Antibiot. 1977, 30: 571 - For enantioselective synthesis, see:
-
2a
Gebauer J.Blechert S. J. Org. Chem. 2006, 71: 2021 -
2b
Lee W.Shin HJ.Chang S. Tetrahedron: Asymmetry 2001, 12: 29 -
2c
Kobayashi Y.Okui H. J. Org. Chem. 2000, 65: 612 -
2d
Nagarajan M. Tetrahedron Lett. 1999, 40: 1207 -
2e
Sinha SC.Sinha-Bagchi A.Keinan E. J. Org. Chem. 1993, 58: 7789 -
2f
Quinkert G.Kueber F.Knauf W.Wacker M.Koch U.Becker H.Nestler HP.Durner G.Zimmermann G.Bats JW.Egert E. Helv. Chim. Acta 1991, 74: 1853 -
2g
Tatsuta K.Amemiya Y.Kanemura Y.Kinoshita M. Bull. Chem. Soc. Jpn. 1982, 55: 3248 - For racemic synthesis, see:
-
2h
Trost BM.Brickner SJ. J. Am. Chem. Soc. 1983, 105: 568 -
2i
Fujisawa T.Okada N.Takeuchi M.Sato T. Chem. Lett. 1983, 1271 -
2j
Asaoka M.Abe M.Mukuta T.Takei H. Chem. Lett. 1982, 215 -
2k
Asaoka M.Yanagida N.Takei H. Tetrahedron Lett. 1980, 21: 4611 -
3a
Reddy ChR.Rao NN. Tetrahedron Lett. 2009, 50: 2478 -
3b
Reddy ChR.Srikanth B. Synlett 2010, 1536 -
4a
Brown CA.Yamashita A. J. Am. Chem. Soc. 1975, 97: 891 -
4b
Kimmel T.Becker D. J. Org. Chem. 1984, 49: 2494 - 5
Horvath A.Benner J.Backvall J.-E. Eur. J. Org. Chem. 2004, 3240 - 6
Parikh JR.Doering W. v. EvE. J. Am. Chem. Soc. 1967, 89: 5505 -
7a
Ohira S. Synth. Commun. 1989, 19: 561 -
7b
Roth GJ.Liepold B.Müller SG.Bestmann HJ. Synlett 1996, 521 -
7c
Roth GJ.Bernd L.Müller SG.Bestmann HJ. Synthesis 2004, 59 - 8
Hofmeister H.Annen K.Laurent H.Weichert R. Angew. Chem., Int. Ed. Engl. 1984, 23: 727 -
9a
Chodkiewicz W. Ann. Chim. Paris 1957, 2: 819 -
9b
Cadiot P.Chodkiewicz W. In Chemistry of AcetylenesViehe HG. Marcel Dekker; New York: 1969. p.597 - 10
Vatele J.-M. Tetrahedron Lett. 2006, 47: 715 - 11
Inanaga J.Hirata K.Sacki H.Hatsuki T.Yamaguchi M. Bull. Chem. Soc. Jpn. 1979, 52: 1989
References and Notes
Spectral Data
of Representative New Compounds
Compound 9: [α]D
²0 -24.8
(c 1.0, CHCl3). IR (KBr): νmax = 2989,
2933, 2864, 2121, 1726, 1635, 1454, 1376, 1241, 1214, 1086, 852,
740, 398 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 7.30-7.27
(m, 5 H), 4.59 (s, 2 H), 4.49 (dd, J = 2.2,
6.8 Hz, 1 H), 4.25-4.18 (m, 1 H), 3.60 (d, J = 4.5 Hz, 2
H), 2.44 (d, J = 2.2
Hz, 1 H), 1.48 (s, 3 H), 1.41 (s, 3 H). ¹³C
NMR (75 MHz, CDCl3): δ = 137.5, 128.3,
127.7, 127.6, 110.8, 80.8, 80.6, 74.6, 73.5, 68.9, 67.1, 26.8, 26.0.
ESI-HRMS: m/z calcd for C15H18O3Na [M + Na]+:
269.1153; found: 269.1146.
Compound 5: [α]D
²0 -43.0
(c 1.0, CHCl3). IR (KBr): νmax = 2988,
2926, 2214, 1722, 1626, 1376, 1217, 1081, 1022, 851, 742, 700 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 7.34-7.27 (m,
5 H), 4.59 (s, 2 H), 4.53 (d, J = 7.5
Hz, 1 H), 4.35-4.18 (m, 1 H), 3.59 (d, J = 4.5
Hz, 2 H), 1.48 (s, 3 H), 1.41 (s, 3 H). ¹³C
NMR (75 MHz, CDCl3): δ = 137.6, 128.3,
127.6, 127.5, 110.8, 80.4, 76.9, 73.4, 68.9, 68.0, 47.1, 26.8, 26.0. ESI-MS: m/z = 347 [M + Na]+.
Compound 10: [α]D
²0 -59.9
(c 1.0, CHCl3). IR (KBr): νmax = 3426,
2932, 2861, 2254, 1718, 1633, 1454, 1375, 1219, 1087, 1035, 851,
741, 699 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 7.35-7.26
(m, 5 H), 4.57 (s, 2 H), 4.55 (d, J = 6.8
Hz, 1 H), 4.25-4.18 (m, 1 H), 3.80-3.71 (m, 1
H), 3.58 (d, J = 4.5
Hz, 2 H), 2.29 (t, J = 6.8
Hz, 2 H), 1.60-1.36 (m, 8 H), 1.47 (s, 3 H), 1.40 (s, 3
H), 1.17 (d, J = 6.0
Hz, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 137.6,
128.2, 127.5, 127.4, 110.7, 81.9, 80.5, 73.3, 72.0, 71.3, 68.9,
67.6, 67.6, 64.3, 38.8, 28.5, 27.8, 26.7, 25.9, 24.9, 23.2, 18.9.
ESI-MS: m/z = 407 [M + Na]+.
Compound 3: [α]D
²0 -20.7
(c 1.0, CHCl3). IR (KBr): νmax = 3413,
2926, 2856, 1631, 1455, 1374, 1220, 1049, 851, 763 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 3.85-3.80
(m, 1 H), 3.74 (dd, J = 3.0,
12.0 Hz, 2 H), 3.68-3.63 (m, 1 H), 3.54 (dd, J = 4.0, 12.0
Hz, 1 H),1.56-1.25 (m, 18 H), 1.38 (s, 3 H), 1.37 (s, 3
H), 1.17 (d, J = 6.0
Hz, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 108.4,
81.5, 76.9, 68.0, 62.0, 39.2, 33.0, 29.55, 29.51, 29.4, 29.3, 27.2,
26.9, 25.8, 25.6, 23.3. ESI-HRMS: m/z calcd
for C17H34O4Na [M + Na]+:
325.2354; found: 325.2363.
Compound 11: [α]D
²0 -10.3
(c 1.6, CHCl3). IR (KBr): νmax = 3452,
2938, 2855, 1722, 1655, 1373, 1300, 1260, 1169, 1042, 771, 555 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 6.83 (dd, J = 5.0, 15.0
Hz, 1 H), 6.08 (d, J = 15.0
Hz, 1 H), 4.21 (q, J = 7.0
Hz, 2 H), 4.11 (t, J = 7.0
Hz, 1 H), 3.80-3.73 (m, 1 H), 3.69 (q, J = 7.0
Hz, 1 H), 1.61-1.54 (m, 2 H), 1.51-1.22 (m, 16
H), 1.42 (s, 3 H), 1.40 (s, 3 H), 1.31 (t, J = 7.0 Hz,
3 H), 1.18 (d, J = 6.0
Hz, 3 H). ¹³C NMR (75 MHz, CDCl3): δ = 166.0,
144.1, 122.5, 109.2, 80.5, 80.1, 68.0, 60.5, 39.2, 32.0, 29.5, 29.4,
29.3, 27.2, 26.5, 25.8, 25.6, 23.4, 14.1. ESI-HRMS: m/z calcd for C21H38O5Na [M + Na]+: 393.2616;
found: 393.2627.
Compound 2: [α]D
²0 +5.6
(c 0.78, CHCl3). IR (KBr): νmax = 2928,
2856, 1715, 1458, 1374, 1257, 1177, 1055, 987, 862 cm-¹. ¹H
NMR (300 MHz, CDCl3): δ = 6.88 (dd, J = 7.0, 16.0
Hz, 1 H), 6.12 (d, J = 16.0
Hz, 1 H), 5.07-4.99 (m, 1 H), 4.13 (t, J = 7.0
Hz, 1 H), 3.78-3.72 (m, 1 H), 1.86-1.77 (m, 1
H), 1.69-1.58 (m, 2 H), 1.53-1.41 (m, 2 H), 1.43
(s, 3 H), 1.42 (s, 3 H), 1.35-1.18 (m, 13 H), 1.26 (d, J = 6.0 Hz,
3 H). ¹³C NMR (75 MHz, CDCl3): δ = 165.5,
144.3, 123.6, 109.2, 80.7, 80.0, 71.1, 35.2, 31.0, 27.8, 27.2, 27.1,
26.9, 26.5, 26.4, 24.7, 23.3, 20.5. ESI-HRMS: m/z calcd
for C19H32O4Na
[M + Na]+:
347.2198; found: 347.2206.